CDH2 and cancer: Increase in vimentin (Type III intermediate filament protein), N-cadherin (transmembrane glycoprotein) and loss of E-cadherin have been characterized as key molecular alterations during Epithelial-to-Mesenchymal Transition (EMT), a primary step in cancer metastasis.